| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $18.1M | +15.1% |
| SG&A Expense | $9.4M | +5.6% |
| Operating Income | -$27.6M | -11.7% |
| Pre-tax Income | -$26.6M | -13.3% |
| Income Tax | $2K | +0.0% |
| Net Income | -$26.6M | -13.3% |
| EPS (Basic) | -$0.43 | +0.0% |
| EPS (Diluted) | -$0.43 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.2M | -11.6% |
| Current Assets | $17.9M | -12.4% |
| Total Assets | $39.4M | -5.2% |
| Current Liabilities | $6.6M | +10.3% |
| Total Liabilities | $23.7M | -1.2% |
| Stockholders' Equity | $15.7M | -10.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.3M | -17.0% |
| Capital Expenditures | $1.2M | +111.0% |
| Investing Cash Flow | -$1.2M | -111.0% |
| Financing Cash Flow | $23.3M | +22.1% |
| Free Cash Flow | -$25.5M | -19.4% |